Partner Content Partner Content Only two weeks left until the Biobanking 2019 Conference in ... Biobanking 2019 Conference
Partner Content Partner Content Internationally Recognised Biobanks Sign Up To 8th Annual Bi... International Biobanks Sign Up To 8th BioBanking Event
Partner Content Partner Content The National Institutes of Health announce Biobanking Medica... Biobanking in the News
News Chiesi signs $1.9bn deal to buy KalVista and its HAE drug Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
